Further functional experiments confirmed that SHP2 could serve as a downstream target of ALK in NB cells and the combined inhibition of both ALK and SHP2 strongly decreases the proliferation of ALK-driven NB cells. The gene discussed is ALK; the disease is neuroblastoma.